Skip to main content
. 2012 Jul;56(7):3556–3562. doi: 10.1128/AAC.06263-11

Table 2.

Efflux pump inhibitor evaluation

Compound MIC in μg/ml [fold potency loss] for strainF98*
No EPI (F98*/wild type) Reserpine Thioridazine Verapamil
TMP 20 [32] 20 [1.0] 10 [2.0] 5 [4.0]
1 10 [128] 5.0 [2.0] 2.5 [4.0] 2.5 [4.0]
2 20 [16] 20 [1.0] 2.5 [8.0] 10 [2.0]